SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies
Post# of 35800

NEW YORK, Jan. 25, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces it has commenced an investigation of Corcept Therapeutics Incorporated (“Corcept” or “the Company”) (NASDAQCM: CORT) concerning possible violations of federal securities laws. To obtain additional information, go to :
https://www.zlk.com/pslra-1/corcept-therapeut...oss-form-2
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 55 Broadway, 10th Floor New York, NY 10006 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

